These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17987295)

  • 41. Physical link and functional coupling of presynaptic calcium channels and the synaptic vesicle docking/fusion machinery.
    Sheng ZH; Westenbroek RE; Catterall WA
    J Bioenerg Biomembr; 1998 Aug; 30(4):335-45. PubMed ID: 9758330
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estimates of quantal content during 'chemical potentiation' of transmitter release.
    Katz B; Miledi R
    Proc R Soc Lond B Biol Sci; 1979 Aug; 205(1160):369-78. PubMed ID: 41252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quelling of spontaneous transmitter release by nerve impulses in low extracellular calcium solutions.
    Erulkar SD; Rahamimoff R; Rotshenker S
    J Physiol; 1978 May; 278():491-500. PubMed ID: 209170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nerve-evoked synchronous release and high K+ -induced quantal events are regulated separately by synaptotagmin I at Drosophila neuromuscular junctions.
    Tamura T; Hou J; Reist NE; Kidokoro Y
    J Neurophysiol; 2007 Jan; 97(1):540-9. PubMed ID: 17079341
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of opiates on the terminal nerve impulse and quantal secretion from visualized amphibian nerve terminals.
    Lavidis NA
    Br J Pharmacol; 1995 Jun; 115(3):441-50. PubMed ID: 7582455
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transmitter secretion varies between visualized release sites at amphibian neuromuscular junctions.
    Bennett M; Jones P; Lavidis N
    Neurosci Lett; 1986 Apr; 65(3):311-5. PubMed ID: 2872629
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of testosterone on synaptic efficacy at neuromuscular junctions in a sexually dimorphic muscle of male frogs.
    Nagaya N; Herrera AA
    J Physiol; 1995 Feb; 483 ( Pt 1)(Pt 1):141-53. PubMed ID: 7776228
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Localization of synaptotagmin-binding domains on syntaxin.
    Kee Y; Scheller RH
    J Neurosci; 1996 Mar; 16(6):1975-81. PubMed ID: 8604041
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The cocoon of the fossorial frog Cyclorana australis functions primarily as a barrier to water exchange with the substrate.
    Reynolds SJ; Christian KA; Tracy CR
    Physiol Biochem Zool; 2010; 83(5):877-84. PubMed ID: 20687829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Frequency and amplitude gradients of spontaneous release along the length of the frog neuromuscular junction.
    Robitaille R; Tremblay JP
    Synapse; 1989; 3(4):291-307. PubMed ID: 2568018
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular scaffold reorganization at the transmitter release site with vesicle exocytosis or botulinum toxin C1.
    Stanley EF; Reese TS; Wang GZ
    Eur J Neurosci; 2003 Oct; 18(8):2403-7. PubMed ID: 14622203
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuromuscular transmission and muscle contractility in SNAP-25-deficient coloboma mice.
    Adler M; Sheridan RE; Deshpande SS; Oyler GA
    Neurotoxicology; 2001 Dec; 22(6):775-86. PubMed ID: 11829411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Mediator secretion in the nerve-muscle synapse in the frog following long-term effect of calcium-free solutions].
    Zefirov AL; Mukhamedzianov RD; Minlebaev MG; Cheranov SIu; Abdrakhmanov MM; Grigor'ev PN
    Ross Fiziol Zh Im I M Sechenova; 2002 Feb; 88(2):191-204. PubMed ID: 11938649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of botulinum toxin on neuromuscular transmission in the rat.
    Cull-Candy SG; Lundh H; Thesleff S
    J Physiol; 1976 Aug; 260(1):177-203. PubMed ID: 184273
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Munc18a does not alter fusion rates mediated by neuronal SNAREs, synaptotagmin, and complexin.
    Zhang Y; Diao J; Colbert KN; Lai Y; Pfuetzner RA; Padolina MS; Vivona S; Ressl S; Cipriano DJ; Choi UB; Shah N; Weis WI; Brunger AT
    J Biol Chem; 2015 Apr; 290(16):10518-34. PubMed ID: 25716318
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of 4-aminopyridine on neuromuscular transmission.
    Lundh H
    Brain Res; 1978 Sep; 153(2):307-18. PubMed ID: 210882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adrenocorticotropic hormone causes long-lasting potentiation of transmitter release from frog motor nerve terminals.
    Johnston MF; Kravitz EA; Meiri H; Rahamimoff R
    Science; 1983 Jun; 220(4601):1071-2. PubMed ID: 6133353
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transmitter mobilization at the frog neuromuscular junction.
    Alkadhi K; Volle RL
    Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):261-75. PubMed ID: 23083
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Mediator secretion in the proximal and distal portions of a nerve ending of the sartorius muscle in the frog].
    Zefirov AL
    Neirofiziologiia; 1983; 15(4):362-9. PubMed ID: 6137778
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Botulinum toxin and 4-aminoquinoline induce a similar abnormal type of spontaneous quantal transmitter release at the rat neuromuscular junction.
    Thesleff S; Molgó J; Lundh H
    Brain Res; 1983 Mar; 264(1):89-97. PubMed ID: 6133583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.